ARK Invest's position in ALGN, updated every trading day. Data as of 2026-11-12.
| Fund | Shares | Value | Weight | Rank |
|---|---|---|---|---|
| PRNT | 6,216 | $1.0M | 2.01% | #23 |
| Trade day | Fund | Side | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-11 | PRNT | Buy | Added | 875 | $151K |
| 2026-01-16 | PRNT | Sell | Trimmed | 2,084 | $357K |
| 2025-10-17 | PRNT | Buy | Added | 2,951 | $385K |
| 2025-10-02 | PRNT | Buy | New position | 6,208 | $799K |
| 2025-10-01 | PRNT | Sell | Closed position | 6,208 | $777K |
| 2025-07-31 | PRNT | Buy | Added | 62 | $8K |
| 2025-07-18 | PRNT | Buy | Added | 260 | $50K |
| 2025-04-17 | PRNT | Buy | Added | 755 | $129K |
| 2025-01-17 | PRNT | Sell | Trimmed | 268 | $60K |
| 2024-10-18 | PRNT | Buy | Added | 1,058 | $232K |
| 2024-07-19 | PRNT | Buy | Added | 1,616 | $407K |
| 2024-04-19 | PRNT | Sell | Trimmed | 900 | $269K |
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First…
See ALGN's full ARK history since 2024, ARK's estimated cost basis, the conviction score and buy/sell alerts.
Open ALGN on FundWake →Data comes from ARK Invest's public daily holdings and trade files. FundWake is not affiliated with ARK Invest. Nothing here is investment advice.